Modes and duration
- Full-time: 2 years
- Part-time: 2 years
Programme start date
Tuition Fees (2016/17)
- £4,770 (FT) £2,385 (PT)
- £22,180 (FT) £11,090 (PT)
Candidates must have been awarded the University of London MBBS or a registered primary qualification in Medicine and be eligible for full registration or hold limited registration with the UK General Medical Council.
English Language Requirements
If your education has not been conducted in the English language, you will be expected to demonstrate evidence of an adequate level of English proficiency.
The English language level for this programme is: Standard
Further information can be found on our English language requirements page.
Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website.
International applicants can find out the equivalent qualification for their country by selecting from the list below.
Select your country:
- Health inequalities
- Life course influences and healthy ageing
- Quantitative research methods and medical and social statistics
- Dental public health
- Health behaviour research
ESRC, MRC, MRC/ESRC, NIHR, Cancer Research UK, Diabetes UK, Wellcome Trust, European Union and British Heart Foundation studentships have been secured in prior years.
Prospective research students should contact academic departments and research groups to enquire about further funded opportunities.
Scholarships relevant to this department are displayed (where available) below. For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website.
- UK, EU, Overseas students
More scholarships are listed on the Scholarships and Funding website
Students graduating in the last three years have secured employment in local and central government, NHS Trusts and hospitals, clinical trial units and Public Health England (previously known as Health Protection Agency), as well as research posts at UCL and other Higher Education Institutes.
The institute offers world-class education and training. It manages many of the UK’s largest, most comprehensive longitudinal data sets, and evaluates strategies for the prevention and treatment of physical and mental ill health. It carries out innovative work on behaviour change, on the practice of primary care as well as leading applied health and health policy research.
The institute produces graduates with the skills and knowledge sought after by government departments and public sector organisations worldwide, as well as leading academic institutions.
The institute’s research departments collaborate with third sector and governmental organisations, as well as members of the media, both nationally and internationally to ensure the highest possible impact of their work beyond the academic community. Students are encouraged to do internships with relevant organisations where funding permits. Members of staff also collaborate closely with academics from leading institutions globally.
Why study this degree at UCL?
This MD(Res) programme, within the Institute of Epidemiology and Health Care, provides students with an opportunity to develop their research skills within a research department which is internationally recognised as a world leader in social epidemiology and population health. The UK is widely recognised as a world-leader in large, longitudinal cohort and panel studies, many of which are housed within our research departments. Students are supported by supervisory panels of truly multidisciplinary staff, as well as student mentors, and two departmental graduate tutors, and they are encouraged to participate in our annual student-led conference, student poster competition and seminars.
Student / staff ratios › 335 staff › 91 taught students › 153 research students
Department: Institute of Epidemiology and Health Care
"My work concentrates on the natural history of infection using data from HIV seroconverters (HIV-positive people whose date of HIV seroconversion can be reasonably well estimated, usually because they had a previous HIV test which was negative). The data is useful for clinicians and their patients on what to expect in the absence of therapy, and are needed for health-care planning."
Professor Kholoud PorterEpidemiology and Health Care MPhil/PhD, Epidemiology and Public Health MD(Res), Infection and Population Health MPhil/PhD, Primary Care and Population Health PhD
UCL Institute of Clinical Trials and Methodology
Application and next steps
Students are advised to apply as early as possible due to competition for places. Those applying for scholarship funding (particularly overseas applicants) should take note of application deadlines.
For more information see our Applications page.Apply now